HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)

HLB Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 16, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	264,886	934,494	331,363	365,136	378,914	776,712
Market Cap Growth	-69.58%	182.02%	-9.25%	-3.64%	-51.22%	0.46%
Enterprise Value	283,622	946,064	315,400	359,859	380,861	785,427
Last Close Price	3155.00	11152.38	4176.19	5152.98	6290.08	12980.24
Forward PE	-	-	-	-	-	108.87
PS Ratio	4.19	17.01	6.30	8.61	8.69	18.09
PB Ratio	1.56	5.14	1.93	2.85	2.91	7.74
P/TBV Ratio	4.95	6.37	2.21	3.28	3.31	9.64
P/FCF Ratio	54.93	1435.95	109.54	-	-	-
P/OCF Ratio	43.30	725.68	99.60	-	-	-
EV/Sales Ratio	4.48	17.22	6.00	8.49	8.74	18.30
EV/EBITDA Ratio	-	2022.13	-	-	-	-
EV/FCF Ratio	58.81	1453.73	104.26	-	-	-
Debt / Equity Ratio	0.13	0.13	0.06	0.41	0.39	0.13
Debt / EBITDA Ratio	-	49.91	-	-	-	-
Debt / FCF Ratio	4.59	35.88	3.31	-	-	-
Asset Turnover	0.29	0.26	0.27	0.23	0.28	0.33
Inventory Turnover	8.06	8.40	7.70	7.66	13.82	11.14
Quick Ratio	0.92	1.46	1.58	1.24	1.91	1.82
Current Ratio	1.16	1.70	1.86	1.37	2.00	2.07
Return on Equity (ROE)	-4.97%	-12.97%	-1.98%	-8.97%	-15.42%	-19.73%
Return on Assets (ROA)	-2.22%	-2.27%	-2.85%	-2.49%	-4.45%	-5.39%
Return on Invested Capital (ROIC)	-2.52%	-2.46%	-3.06%	-2.60%	-4.70%	-5.91%
Return on Capital Employed (ROCE)	-4.20%	-4.10%	-5.10%	-5.80%	-8.30%	-10.90%
Earnings Yield	-3.02%	-2.44%	-0.69%	-3.11%	-4.54%	-2.18%
FCF Yield	1.82%	0.07%	0.91%	-3.34%	-3.19%	-1.51%
Buyback Yield / Dilution	-2.60%	-6.36%	-14.46%	-10.86%	-7.26%	-4.63%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.